Omalizumab decreases IgE production in patients with severe allergic asthma

被引：0
|
作者：
Huebner, Marisa [1 ]
Korn, Stephanie [1 ]
Jung, Matthias [1 ]
Buhl, Roland [1 ]
机构：
[1] Mainz Univ Hosp, Pulm Dept, Mainz, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Allergy; Asthma; -; management; Biomarkers;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
5160
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Free serum IgE concentration in severe persistent allergic asthma patients during omalizumab therapy. A preliminary study
    Zietkowski, Ziemowit
    Czarniakowska-Boltuc, Malgorzata
    Skiepko, Roman
    Lukaszyk, Mateusz
    Bodzenta-Lukaszyk, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2013, 18 (02): : 110 - 113
  • [42] Omalizumab improves asthma-related quality of life in patients with severe allergic asthma
    Finn, A
    Gross, G
    van Bavel, J
    Lee, T
    Windom, H
    Everhard, F
    Fowler-Taylor, A
    Liu, J
    Gupta, N
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (02) : 278 - 284
  • [43] Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    Ilvan, Ahmet
    Nayci, Sibel Atis
    JOURNAL OF ASTHMA, 2013, 50 (06) : 687 - 694
  • [44] Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma - real life experience from Czech Anti-IgE Registry
    Hutyrova, Beata
    Bystron, Jaromir
    Chlumsky, Jan
    Kindlova, Dagmar
    Klosova, Jana
    Krcmova, Irena
    Novotna, Bronislava
    Panzner, Petr
    Pohunek, Petr
    Ruzickova-Kirchnerova, Olga
    Sedlak, Vratislav
    Terl, Milan
    Vanik, Petr
    Vasakova, Martina
    Vernerova, Eva
    Zatloukal, Jaromir
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [45] Omalizumab, an anti-IgE monoclonal antibody, demonstrates long-term asthma control, safety and tolerability in patients with severe allergic asthma
    Hébert, J
    Rolli, M
    Gao, J
    Reisner, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S9 - S9
  • [46] Omalizumab therapy reduces asthma exacerbations and is rated as effective by physicians in children with severe allergic (IgE-mediated) asthma
    Kulus, M.
    Hebert, J.
    Garcia, E.
    Taylor, A. F.
    Vidaurre, C. F.
    Blogg, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (12): : 1952 - 1952
  • [47] Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience
    Jain, Salina
    Saralaya, Dinesh
    Regan, Karen
    Walker, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [48] Treating moderate-to-severe allergic asthma with antiIg-IgE monoclonal antibody (omalizumab). An Update
    D'Amato, G.
    Perticone, M.
    Bucchioni, E.
    Salzillo, A.
    D'Amato, M.
    Liccardi, G.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 41 (04) : 135 - 140
  • [49] Real-life Effectiveness Of Omalizumab In Patients With Severe Persistent Allergic (IgE-Mediated) Asthma At A Single UK Hospital
    Simons, A.
    Regan, K.
    Aziz, A.
    Saralaya, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [50] Clinical efficacy and safety of omalizumab in severe allergic asthma
    Kogkas, S.
    Retsas, P.
    Liapis, C.
    Chatzipetrou, A.
    Aggelides, X.
    Chliva, C.
    Makris, M.
    ALLERGY, 2012, 67 : 462 - 462
12345